Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect.
Guardalupi F, Sorrentino C, Corradi G, Giancola R, Baldoni S, Ulbar F, Fabi B, Andres Ejarque R, Timms J, Restuccia F, Santarone S, Accorsi P, Sportoletti P, De Falco F, Rosati E, Carotti A, Falzetti F, Velardi A, Martelli MF, Kordasti S, Pierini A, Ruggeri L, Di Ianni M. Guardalupi F, et al. Among authors: velardi a. Leukemia. 2023 Jul;37(7):1572-1575. doi: 10.1038/s41375-023-01932-x. Epub 2023 Jun 7. Leukemia. 2023. PMID: 37286785 Free PMC article. No abstract available.
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A, Labopin M, Swoboda R, Kulagin A, Velardi A, Sanz J, Labussière-Wallet H, Potter V, Kuball J, Sica S, Parovichnikova E, Bethge W, Maillard N, Platzbecker U, Stölzel F, Ciceri F, Mohty M. Nagler A, et al. Among authors: velardi a. Bone Marrow Transplant. 2023 Sep;58(9):1008-1016. doi: 10.1038/s41409-023-02012-5. Epub 2023 May 30. Bone Marrow Transplant. 2023. PMID: 37253804
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party.
Greco R, Hoogenboom JD, Bonneville EF, Anagnostopoulos A, Cuoghi A, Dalle JH, Weissinger EM, Lang P, Galaverna F, Martino M, Maschan A, Mauz-Körholz C, Noviello M, Passweg J, Peccatori J, Rovira M, Solano C, Veelken H, Velardi A, Wagner-Drouet EM, Zhang X, Ciceri F, Bonini C, Vago L, Ruggeri A, Chabannon C. Greco R, et al. Among authors: velardi a. Bone Marrow Transplant. 2023 May;58(5):603-606. doi: 10.1038/s41409-023-01939-z. Epub 2023 Feb 22. Bone Marrow Transplant. 2023. PMID: 36813866 Free PMC article. No abstract available.
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation.
Mancusi A, Zorutti F, Ruggeri L, Bonato S, Tricarico S, Zei T, Iacucci Ostini R, Viglione V, Sembenico R, Sciabolacci S, Cardinali V, Martelli MF, Mecucci C, Carotti A, Martelli MP, Velardi A, Pierini A. Mancusi A, et al. Among authors: velardi a. Int J Mol Sci. 2023 Nov 9;24(22):16105. doi: 10.3390/ijms242216105. Int J Mol Sci. 2023. PMID: 38003295 Free PMC article.
HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia.
Massei MS, Capolsini I, Mastrodicasa E, Perruccio K, Arcioni F, Cerri C, Gurdo G, Sciabolacci S, Falzetti F, Zei T, Iacucci Ostini R, Brogna M, Panizza BM, Saldi S, Merluzzi M, Tognellini R, Marchesi M, Minelli O, Aristei C, Velardi A, Pierini A, Ruggeri L, Martelli MF, Carotti A, Caniglia M. Massei MS, et al. Among authors: velardi a. Bone Marrow Transplant. 2023 May;58(5):526-533. doi: 10.1038/s41409-023-01911-x. Epub 2023 Feb 11. Bone Marrow Transplant. 2023. PMID: 36774432 Free PMC article.
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Saldi S, Fulcheri CPL, Zucchetti C, Abdelhamid AMH, Carotti A, Pierini A, Ruggeri L, Tricarico S, Chiodi M, Ingrosso G, Bini V, Velardi A, Martelli MF, Hui SK, Aristei C. Saldi S, et al. Among authors: velardi a. Front Oncol. 2022 Dec 8;12:1035375. doi: 10.3389/fonc.2022.1035375. eCollection 2022. Front Oncol. 2022. PMID: 36568236 Free PMC article.
Donor natural killer cells trigger production of β-2-microglobulin to enhance post-bone marrow transplant immunity.
Ruggeri L, Urbani E, Chiasserini D, Susta F, Orvietani PL, Burchielli E, Ciardelli S, Sola R, Bruscoli S, Cardinale A, Pierini A, Piersma SR, Pasquino S, Locatelli F, Ramarli D, Velardi E, Binaglia L, Jimenez CR, Holländer GA, Velardi A. Ruggeri L, et al. Among authors: velardi a. Blood. 2022 Dec 1;140(22):2323-2334. doi: 10.1182/blood.2021015297. Blood. 2022. PMID: 35984965 Free article.
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters.
Parisi S, Ruggeri L, Dan E, Rizzi S, Sinigaglia B, Ocadlikova D, Bontadini A, Giudice V, Urbani E, Ciardelli S, Sartor C, Cristiano G, Nanni J, Zannoni L, Chirumbolo G, Arpinati M, Lewis RE, Bonifazi F, Marconi G, Martinelli G, Papayannidis C, Paolini S, Velardi A, Cavo M, Lemoli RM, Curti A. Parisi S, et al. Among authors: velardi a. Front Immunol. 2022 Jan 31;12:804988. doi: 10.3389/fimmu.2021.804988. eCollection 2021. Front Immunol. 2022. PMID: 35173709 Free PMC article.
223 results